General chemistry banner image
General chemistry banner image
General chemistry banner image

Every laboratory requires a high-quality test menu to help meet their requirements for reliable, accurate and precise immunoassay testing results. With Abbott, labs avoid interference complications with our Biotin-interference free assays.

Driving diagnostic innovation since 1972

In 1972, Abbott launched its first hepatitis test and in 1985 launched the world's first FDA approved HIV test. Our innovations and commitment to the science of laboratory diagnostics marked the beginning of our modern diagnostics business. With more than 50 years dedicated to improving lives through quality diagnostics, scientists are continually developing innovative systems and tests across infectious disease, cardiac, oncology, and more.

Achieve measurably better healthcare performance with our personalized solutions,

including comprehensive immunoassays

Resourceful Advocates

Expert teams take a holistic, enterprise-level view to develop personalized solutions for laboratories.


A harmonized family of innovative systems, assays, informatics, and automation solutions that streamline laboratory operations.


Abbott’s portfolio of AlinIQ Digital Health Solutions unlocks intelligent, actionable insights throughout the entire diagnosis cycle to achieve operational and clinical excellence.

Diagnostics panels



The robust cancer menu supports laboratories and physicians for patients diagnosed with liver, lung and ovarian cancer. Our advanced tumor markers provide precise and accurate results to help inform treatment plans.


The comprehensive cardiac menu aids with cardiovascular disease identification, prediction and management to help improve patients' lives and instill confidence in cardiac care decision making.

Infectious disease

Abbott’s 30-year commitment to viral surveillance, the Abbott Pandemic Defense Coalition, and our rich legacy of introducing innovative solutions help provide customers the confidence they need to protect communities.


A game changing combination of brain biomarkers in Abbott’s novel TBI assay enables the rule out of intracranial lesions for patients with suspected mTBI and has the potential to rule out unnecessary CT scans. 


Alinity is Abbott’s next generation of systems, across key laboratory disciplines, designed to simplify diagnostics and help you deliver results that drive better patient outcomes. With Alinity, critical interactions between individuals, systems and information are streamlined, enabling you to redefine performance in your laboratory and your institution. Alinity is a total lab solution, designed to deliver: uniformity, flexibility, operational productivity and confidence.

ARCHITECT is a proven solution with true family commonality and enhanced system and assay dynamics, the ARCHITECT family allows for core lab integration without compromise. With multiple platform combinations for all your laboratory’s needs, ARCHITECT helps maximizes ease of use through common reagent sharing, sample carriers, software and instrument consumables.


Knowledge Center

Find the latest information in laboratory science, therapeutic areas and Abbott innovation.

Customer Portal

Receive exclusive benefits and resources when you register to access to the Customer Portal.

Contact Us

Abbott's Representatives are ready to offer support, gather feedback, and answer any questions.